Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Florian Dieckmann
Order vs. Opportunity: What My American Journey Taught Me About Cultural DNA
I am back in the U.S. for this 4th of July and this time, it hits differently. As fireworks light up the Midwestern sky and the smell of barbecue wafts through the neighborhood, I find myself contemplating what it means to belong to two worlds. After five years in Chicago, I moved back to Germany in 2021. Now I am back on vacation visiting with my family. My wife is American, our kids are dual citizens.
PSD Bank Rhein-Ruhr eG
Grünenthal delivers exceptional financial results in 2024, powered by strategic growth and Valinor acquisition in the US EQS-News: Grünenthal GmbH / Key word(s): Annual Results Grünenthal delivers exceptional financial results in 2024, powered by strategic growth and Valinor acquisition in the US 27.03.2025 / 09:31 CET/CEST The issuer is solely responsible for the content of this announcement.
Berliner Volksbank eG
Grünenthal successfully places new EUR500 million bond EQS-News: Grünenthal GmbH / Key word(s): Bond/Issue of Debt Grünenthal successfully places new EUR500 million bond 06.12.2024 / 13:17 CET/CEST The issuer is solely responsible for the content of this announcement.
PSD Bank Rhein-Ruhr eG
Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions EQS-News: Grünenthal GmbH / Key word(s): Annual Results Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions 25.03.2024 / 09:30 CET/CEST The issuer is solely responsible for the content of this announcement.
Grünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee
Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. Grünenthal is running a global Phase III programme to investigate the efficacy and safety of intra-articular injections of resiniferatoxin, a non-opioid therapy, in adults with pain associated with knee osteoarthritis.
PSD Bank Rhein-Ruhr eG
Nachrichtendetail 25.04.2023 12:51:44 - dpa-AFX: EQS-News: Grünenthal GmbH: Grünenthal successfully places new EUR300 million bond (english) Grünenthal GmbH: Grünenthal successfully places new EUR300 million bond EQS-News: Grünenthal GmbH / Key word(s): Issue of Debt/Bond Grünenthal GmbH: Grünenthal successfully places new EUR300 million bond 25.04.2023 / 12:51 CET/CEST The issuer is solely responsible for the content of this announcement.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Florian
Contact Florian, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack